Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$128,329,182
+$29,115,129 QoQ
Shares Held
1,132,050
+7.4% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Sep 30, 2021CallValue
$309,510
CallShares
4,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. INCY ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
This page
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in INCY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,329,182 | 1,132,050 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $99,214,053 | 1,054,123 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $110,265,045 | 1,116,382 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $126,007,218 | 1,485,759 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,118,263 | 427,581 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $11,823,051 | 195,261 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $14,468,712 | 209,479 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,131,765 | 168,408 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,756,981 | 144,457 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $31,104,422 | 545,979 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $42,883,806 | 682,972 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $57,021,989 | 987,052 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,156,586 | 532,636 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $915,508,837 | 12,667,896 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $758,279,666 | 9,440,733 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $613,544,546 | 9,206,851 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $695,175,860 | 9,150,663 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $610,164,159 | 7,682,752 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $259,409,762 | 3,534,193 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $309,510 | 4,500 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $220,058,578 | 3,199,456 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $212,806,660 | 2,529,498 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $748,757 | 8,900 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $184,925,164 | 2,275,442 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $172,737,575 | 1,985,946 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $152,002,771 | 1,693,813 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $159,302,514 | 1,532,197 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $112,482,592 | 1,536,018 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||